We will inform you about new products and answer your questions
header
DON’T PUT YOUR RESEARCH IN FLUX
IP-One assay delivers more predictable, pharmacologically relevant results for GPCR-screening.
When it comes to drug discovery research using GPCRs, accurate Gαq-signaling is essential in order to find biased molecules of therapeutic importance.
Cisbio Bioassays introduces IP-One, an HTRF assay that detects the accumulation of Inositol-1-Phosphate (IP1), an analyte solely produced by G-protein receptors. IP-One enables you to:
Precisely identify Gαq drug targeted candidates
Ensure signal specificity
Reduce the false positives often seen with calcium flux assays
Obtain more pharmacologically relevant lead molecules
With IP-One you can achieve excellence in high throughput screening, improve lab productivity and boost confidence in your results.
header
Screen Smarter
SEE THE IP-ONE DIFFERENCE
Call 888-963-4567 to order and receive 30% off a trial kit.
Offer valid for first-time users until October 31, 2015.